National Institutes of Health Consensus Development Conference Statement: management of hepatitis B.
about
The Infectious Diseases Society of America Lyme guidelines: a cautionary tale about the development of clinical practice guidelinesHepatitis B Reactivation with Novel Agents in Non-Hodgkin's Lymphoma and Prevention StrategiesHigh prevalence of hepatitis B virus infection among pregnant women attending antenatal care: a cross-sectional study in two hospitals in northern UgandaSafety and efficacy of telbivudine for the treatment of chronic hepatitis BHepatitis B virus and its sexually transmitted infection - an update.Current hepatitis B treatment guidelines and future research directions.Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association.Pregnancy outcomes associated with viral hepatitis.Non-ALT biomarkers for markedly abnormal liver histology among Chinese persistently normal alanine aminotransferase-chronic hepatitis B patientsAssociation of genetic variation of sodium taurocholate cotransporting polypeptide with chronic hepatitis B virus infection.Medical care of hepatitis B among Asian American populations: perspectives from three provider groups.Understanding the natural history of chronic HBV and HCV infectionsPros and Cons of Peginterferon Versus Nucleos(t)ide Analogues for Treatment of Chronic Hepatitis B.A microarray analysis of early activated pathways in concanavalin A-induced hepatitis.Sequences in the terminal protein and reverse transcriptase domains of the hepatitis B virus polymerase contribute to RNA binding and encapsidationHepatitis B virus replication is blocked by a 2-hydroxyisoquinoline-1,3(2H,4H)-dione (HID) inhibitor of the viral ribonuclease H activityBarriers to screening for hepatitis B virus infection in Asian Americans.High-dose clevudine impairs mitochondrial function and glucose-stimulated insulin secretion in INS-1E cells.Chronic hepatitis B in 2014: great therapeutic progress, large diagnostic deficit.Recent advances in managing hepatitis B.Comparison of noninvasive models of fibrosis in chronic hepatitis B.Hepatitis B assays in serum, plasma and whole blood on filter paper.Evaluation and management of hepatitis B in pregnancy: a survey of current practicesClinical characteristics and current management of hepatitis B and C in China.Combination treatment in HBeAg-negative chronic hepatitis B.Cost-effectiveness analysis of different rescue therapies in patients with lamivudine-resistant chronic hepatitis B in China.Adherence to chronic hepatitis B treatment guideline recommendations for laboratory monitoring of patients who are not receiving antiviral treatment.Seroprevalence of hepatitis B and C virus infection among patients attending serology laboratory of Gondar University HospitalValidation of three coding algorithms to identify patients with end-stage liver disease in an administrative database.The cost-effectiveness of screening for chronic hepatitis B infection in the United States.New approaches in the management of chronic hepatitis B: role of tenofovir.Comparison of histologic characteristics of Chinese chronic hepatitis B patients with persistently normal or mildly elevated ALTHepatitis B virus large surface protein: function and fame.Technical standards for hepatitis B virus X protein (HBx) research.Hydroxylated tropolones inhibit hepatitis B virus replication by blocking viral ribonuclease H activity.Recent trends in hepatic diseases during pregnancy in the United States, 2002-2010.The hepatitis B virus ribonuclease H as a drug targetWhen treating cancer, please don't forget hepatitis B.Management of hepatitis B in developing countries.Prevalence of hepatitis B and C and sensibility of a selective screening questionnaire in patients receiving chemotherapy for solid tumors.
P2860
Q24288916-30E85016-FBA6-41C6-99C9-BF5F64BB6E12Q26746486-688F5735-E0C5-4404-8041-4F4CE3E033E0Q28651407-3BECB6CC-331D-4971-9E3E-41009AFEDB33Q28972486-D68953ED-4C2D-4594-87A5-DCE7D8A5F4C1Q30235028-C0AC4B1B-7762-4C78-8100-F89B3D03A8E9Q30487002-BB710475-298E-49DA-8275-FCC1D6D950F5Q30634658-12BEA329-E214-428D-A505-7961DB2E7F64Q33395866-FC1F962A-07E7-426E-A514-A0AC0B964578Q33599576-1FE1F7E1-F0A8-4E97-B168-D7928875BE20Q33705688-4ED1A35C-0ACB-464E-9F47-64B3BDA64748Q33730890-22B44F2B-D8AE-41C7-ADD2-BE516B9B7D43Q33817582-A59BD503-9424-481A-9ACA-0D6126092495Q33819124-61BCDAE0-44E3-4FDD-8CC3-5EDEA9306B72Q33834632-9B2FD026-75AD-4C1D-9FC9-A4D0DCA0A5E0Q33875691-77C4C758-A9EE-4A35-805C-0CB32D08886BQ33911464-861D72DB-37B2-4DFD-A9D7-304AD91B02BCQ34000950-28154EF4-2C58-4613-AC7C-EF48C9DD13FDQ34121999-4240E13F-8471-47A2-AF84-2EEDE2AC0277Q34137291-A6E02FB7-67AA-45D8-B004-E5C9928B7F32Q34167574-E4B47BC9-9AE9-4522-A2EF-C16041E88940Q34199677-DCF0D088-74D0-4B2B-A19C-7F097199DFFAQ34274123-175E8294-A41E-43A1-913A-64647142F4C2Q34293333-520AD2AC-7107-4330-8327-ADCF097798DDQ34303075-7988A7EA-67C3-4391-A76B-ED6A2BA0EA8EQ34391476-72364571-D821-47D2-B66A-FAC4BD7FD0BDQ34471072-62D1B138-439B-40E5-BA2F-DCCA62C8541EQ34594451-474A2AE6-80C4-4199-86F6-1544A53946B0Q34687555-8ABDB582-AF2A-464D-859B-24B2074EB790Q34708289-C1D090CE-EE64-4E7F-8CCF-F017C79BA64CQ34990604-85DF3573-4876-40B4-B2E4-8A0BC23E0A92Q35026531-2321794C-EB93-429F-A035-B07D6DFAA2C2Q35049139-74E54ED1-C718-4874-92CA-830FEE0009ABQ35055364-7AC8FB54-E91A-49D1-815E-1A6E9551DC32Q35060821-8F373E20-540A-47A2-AB96-F8A19F508211Q35105877-8689BB69-7CF5-4A2A-AB72-347E3695F245Q35286801-55CD36A3-B03B-4129-B1C2-92B847CB2DF8Q35582561-6CEE7CE7-C338-409B-9BD5-AE763B740805Q35584210-834118E7-54CF-4F40-87B2-4BC22EA0C1F7Q35635637-5BA35BE9-92B4-49C5-8CB8-EBFEBB474D12Q35875680-4D412707-2120-4D98-B7EF-F40897689117
P2860
National Institutes of Health Consensus Development Conference Statement: management of hepatitis B.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
National Institutes of Health ...... nt: management of hepatitis B.
@en
type
label
National Institutes of Health ...... nt: management of hepatitis B.
@en
prefLabel
National Institutes of Health ...... nt: management of hepatitis B.
@en
P2093
P1476
National Institutes of Health ...... nt: management of hepatitis B.
@en
P2093
Doris B Strader
Earl R Kern
Gloria M Petersen
Hartwell T Trotter
Ilana F Gareen
James A McHugh
Jean L Grem
John M Inadomi
Jose Costa
Michael F Rein
P304
P356
10.7326/0003-4819-150-2-200901200-00100
P407
P577
2009-01-05T00:00:00Z